$608.49
7.171.19%
Last update: Nov 4, 4:39 PM
United Therapeutics Corp
UTHRNASDAQ
The average analyst price target for United Therapeutics is $554.87, 8.8% below the current price. Of 16 analysts, 14 rate it Buy, 1 Hold and 1 Sell. Targets range from $302 to $768. The latest change came on Nov 4, 2026, when BTIG raised its price target on United Therapeutics from $728 to $768 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
